key: cord-1041542-8vbxfy80
authors: Warren, Alex; Camporota, Luigi; Vuylsteke, Alain
title: Surge capacity and updated admission criteria: response of the NHS-commissioned national respiratory ECMO network to the COVID-19 pandemic
date: 2020-06-10
journal: Br J Anaesth
DOI: 10.1016/j.bja.2020.06.008
sha: 0e6f7eecb84a36f6b1d1a3068adb7b72dc2775b8
doc_id: 1041542
cord_uid: 8vbxfy80

nan

At the start of the response to COVID-19 and in the absence of previous disease-specific data to guide decision-making in patients with COVID-19, the ECMO service agreed to be more explicit with the referral criteria (Table 1) to assist clinicians in identifying potential patients 4 . Although the scoring systems listed have not been validated in some patient populations (e.g. Clinical Frailty Score 5 in patients < 65 yr old), and clearly not validated in COVID-19 viral pneumonitis, the aim of the criteria is to standardise and triage patients on referral. In addition, this strategy ensures that clinicians should involve at least one other ECMO centre in deciding if it is appropriate to proceed with a patient with a lower probability of benefit (e.g., lower RESP score 6 ).

We would emphasise that these criteria cannot be extrapolated to other conditions. For example, the UK dataset shows that some non-COVID conditions are very likely to benefit from ECMO support (asthma and trauma are associated with survival of 95% and 84%, respectively) 1 . Therefore, clinicians should continue to refer those patients they believe may benefit from ECMO, understanding that these modified referral criteria are not absolute but part of a dynamic shared decision-making process between the referring team and the ECMO service. • If RESP score 6 ≤3 ECMO should be considered only after agreement across at least two centres. Exclusion Criteria:

• Refractory multi-organ failure

Outcomes of the NHS ECMO national extracorporeal membrane oxygenation service for adults with respiratory failure: a multicentre observational cohort study

Referral to an Extracorporeal Membrane Oxygenation Center and Mortality Among Patients With Severe 2009 Influenza A(H1N1)

Efficacy and Economic Assessment of Conventional Ventilatory Support Versus Extracorporeal Membrane Oxygenation for Severe Adult Respiratory Failure (CESAR): A Multicentre Randomised Controlled Trial

A global clinical measure of fitness and frailty in elderly people

Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score